Core Viewpoint - The company announced that it expects to launch cat interferon in the market this year, while the development of the cat quadrivalent vaccine is still ongoing [1] Group 1 - The company is actively preparing to advance its research and development efforts for the cat quadrivalent vaccine and aims to enter clinical trials as soon as possible [1]